Facts of Perjeta (pertuzumab)
PERJETA (pertuzumab) Injection, for intravenous use
Initial U.S. Approval: 2012
Brand Name: Perjeta
Generic Name: pertuzumab
Manufacturer: F. Hoffmann La Roche ltd
Pack Size: 1’s
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Perjeta (pertuzumab)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Perjeta (pertuzumab) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Perjeta is?
PERJETA is a HER2/neu receptor antagonist indicated in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
What pertuzumab is?
Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase survival.